Clinical utility of biochemical markers in colorectal cancer - European Group on Tumour Markers (EGTM) guidelines

Author： Duffy M.J. van Dalen A. Haglund C. Hansson L. Klapdor R. Lamerz R. Nilsson O. Sturgeon C. Topolcan O.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.39, Iss.6, 2003-04, pp. : 718-727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular markers in colorectal cancer: clinical relevance in stage II colon cancer

By Santos Cristina Vilar Eduardo Capella Gabriel Salazar Ramon

Colorectal Cancer, Vol. 2, Iss. 3, 2013-06 ,pp. : 243-263

Future Medicine

Access to resources Recommend Favorite

Tumour markers in prostate cancer III: Biomarkers in urine

By Roobol Monique J. Haese Alexander Bjartell Anders

Acta Oncologica, Vol. 50, Iss. 1, 2011-06 ,pp. : 85-89

Informa Healthcare

Access to resources Recommend Favorite

Molecular markers and the future of colorectal cancer screening

By Carvalho Beatriz Bosch Linda JW Van Engeland Manon Meijer Gerrit A

Colorectal Cancer, Vol. 2, Iss. 2, 2013-04 ,pp. : 95-97

Future Medicine

Access to resources Recommend Favorite

Evaluation of predictive markers for patients with advanced colorectal cancer

By Byström Per Berglund Åke Nygren Peter Wernroth Lisa Johansson Birgitta Larsson Anders Glimelius Bengt

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 849-859

Informa Healthcare

Access to resources Recommend Favorite

Molecular and clinical risk markers in colon cancer trials

By Hill M.J.

European Journal of Cancer, Vol. 36, Iss. 10, 2000-06 ,pp. : 1288-1291

Elsevier

Access to resources Recommend Favorite